Novel Drugs Against Tuberculosis: A Clinician's Perspective

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00162314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Exploring Prospects of Novel Drugs for Tuberculosis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2012English

The Development of Novel Vaccines Against Tuberculosis

Japanese Journal of Clinical Immunology
2008English

Novel Human Recombinant Antibodies Against Mycobacterium Tuberculosis Antigen 85B

BMC Biotechnology
Biotechnology
2014English

Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Cost-Effectiveness of Rapid Susceptibility Testing Against Second-Line Drugs for Tuberculosis

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2014English

Lipids: A Clinician's Guide

Postgraduate Medical Journal
Medicine
1980English

High Throughput Virtual Screening to Identify a Novel Inhibitor Against Pyrazinamide Resistant Tuberculosis

Canadian Journal of Biotechnology
2017English

The Evaluation of Susceptibility of Mycobacterium Tuberculosis Complex Isolates Against Primer Antituberculosis Drugs

ANKEM Dergisi
2012English

Three-Dimensional Structure of M. Tuberculosis Dihydrofolate Reductase Reveals Opportunities for the Design of Novel Tuberculosis Drugs

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy